1. Neurological Disease

Neurological Disease

A range of neurological disorders, including epilepsy and dystonia, may involve dysfunctional intracortical inhibition, and may respond to treatments that modify it. Parkinson’s is a neurodegenerative disease characterized by increased activity of GABA in basal ganglia and the loss of dopamine in nigrostriatum, associated with rigidity, resting tremor, gait with accelerating steps, and fixed inexpressive face. Neurological deficits, along with neuromuscular involvement, are characteristic of mitochondrial disease, and these symptoms can have a dramatic impact on patient quality of life. Neurological features may be manifold, ranging from neural deafness, ataxia, peripheral neuropathy, migraine, seizures, stroke‐like episodes and dementia and depend on the part of the nervous system affected.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-U00394
    Oiligodendrocyte differentiation promoter 1 400760-25-0
    Oiligodendrocyte differentiation promoter 1 belongs to the oiligodendrocyte differentiation promoter.
    Oiligodendrocyte differentiation promoter 1
  • HY-U00397
    CB1 antagonist 1 890037-68-0
    CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions.
    CB1 antagonist 1
  • HY-U00400
    PF-592379 710655-15-5
    PF-592379 is a potent dopamine D3 receptor agonist with an EC50 of 21 nM.
    PF-592379
  • HY-U00402
    Fenmetozole Tosylate 83474-08-2
    Fenmetozole Tosylate is an antagonist of the actions of ethanol, also antagonizes α2-adrenergic receptor, and acts as an antidepressant agent.
    Fenmetozole Tosylate
  • HY-U00408
    5-HT3 antagonist 2 128199-93-9
    5-HT3 antagonist 2 is a 5-HT3 receptor antagonist.
    5-HT3 antagonist 2
  • HY-U00413
    5-HT3-In-1 186348-68-5
    5-HT3-In-1 is extracted from patent EP0748807A1, compound example 8. It shows 5-HT3 inhibition activity.
    5-HT3-In-1
  • HY-U00415
    Benzamide Derivative 1 108226-05-7
    Benzamide Derivative 1 is a benzamide derivative from patent EP0213775A1, compound 18. Benzamide Derivative 1 may be useful in treatment of gastrointestinal disorders.
    Benzamide Derivative 1
Cat. No. Product Name / Synonyms Application Reactivity